Lily C. Chao

Lily C. Chao, MD is a Clinical Associate Professor of Pediatrics at the University of Southern California. Her research focuses on mechanisms regulating muscle metabolism and growth, particularly the role of the nuclear receptor Nur77 (NR4A1) in skeletal muscle and its implications for conditions like diabetes and muscle wasting. She leads studies on Nur77's role in glucose utilization, muscle regeneration, and diabetic myopathy.

Research Interests: Dr. Chao's work integrates metabolism and muscle mass signaling, with translational applications in diabetes, muscular dystrophy, and cachexia. Key projects investigate Nur77's function in muscle development and diabetic complications.

Publications Trends: Her recent articles address youth-onset type 2 diabetes, pandemic impacts on pediatric metabolic disorders, and advancements in diabetes technology (e.g., insulin pumps, continuous glucose monitors). Studies emphasize healthcare disparities, treatment efficacy, and pandemic-related clinical challenges.

Awards:

• Early Investigator Award (Endocrine Society, 2014)
• Clinical Research Scholar (Pediatric Endocrine Society, 2013)
• Pasadena Magazine’s Top Doctors (2011–2014)
• Fellow’s Basic Research Award (Society of Pediatric Research, 2007)
• Howard Hughes Medical Institute-NIH Research Scholar (1999)

Advising & Grants: While specific grants are not listed, her publications suggest involvement in multi-institutional trials (e.g., TODAY study) and NIH-funded research. She collaborates broadly in pediatric endocrinology and diabetes care innovation.

Labs/Teams: Her research is conducted within the CHLA-Saban Research Institute, focusing on translational pediatric endocrinology and metabolic disorders.